Register

Login

Vet Times logo
+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs
Vet Times logo

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcastsDigital Edition

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

Vet Times logo 2

About

The team

Advertise with us

Recruitment

Contact us

Vet Times logo 2

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts

Digital Edition


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

fb-iconinsta-iconlinkedin-icontwitter-iconyoutube-icon

© Veterinary Business Development Ltd 2025

IPSO_regulated

23 Feb 2015

Use of dual active wormers and how they fit with SCOPS’ principles

author_img

Louise Silk

Job Title



Use of dual active wormers and how they fit with SCOPS’ principles

A dual active anthelmintic contains two different classes of anthelmintic with similar spectrums of activity.

An example would be two classes of anthelmintic that target nematodes, such as a levamisole (2-LV) and a macrocyclic lactone (3-ML). These must be distinguished from combination anthelmintics that contain anthelmintics with very different spectrums of activity – for example, a flukicide and a product that targets nematodes, such as triclabendazole and a 3-ML.

The principle behind a combination anthelmintic product is to broaden the range of worm species targeted. The aim of a dual active is to provide effective worm control in the face of anthelmintic resistance as well as to slow the rate of anthelmintic resistance to the component chemicals.

Background

Dual and multiple actives have been used for many years in some parts of the world – particularly in the southern hemisphere. They make up 50 per cent of the sheep wormers available on the market in New Zealand and are also available for cattle. They include a multitude of combinations of anthelmintic classes such as benzimidazole (1-BZ) plus levamisole (2-LV), 2-LV plus 3-ML, as well as 1-BZ plus 2-LV plus 3-ML. This type of product was not available in the UK until 2012 when a new dual active product containing derquantel and abamectin was launched. This product is only available as a POM-V.

Derquantel is from a new anthelmintic class known as the 5-SI or spiroindoles (purple wormers). It is only available in a dual active product, combined with abamectin, a 3-ML (clear wormer). Derquantel is a nicotinic cholinergic antagonist with a novel action that blocks neuromuscular transmission, inducing flaccid paralysis in nematodes. Abamectin acts on glutamate-gated chloride channels and gamma-aminobutyric acid (GABA) neurotransmission sites in nematodes, blocking inter-neuronal stimulation of inhibitory motor neurones, also leading to flaccid paralysis.

Why use a dual active?

There are two justifications for using dual active products. These are:

  • to slow the development of anthelmintic resistance to the component anthelmintic classes
  • to enable the control of nematodes in the presence of single or multiple drug resistance

Slow development of anthelmintic resistance

When resistant alleles are rare the number of parasites in the population with resistant alleles to two unrelated products is exceedingly low. Using a dual active will therefore remove all, or nearly all, of the resistant alleles from the exposed population and keep the resistant alleles very rare (SCOPS, 2012). This will result in a lower number of parasites with resistance to each of the component classes surviving within the population and, therefore, reduce the number available to reproduce and form part of the next generation, thus slowing the rate of resistance development.

Studies on insects in relation to resistance to pesticides has produced a number of prerequisite conditions required to slow the rate of resistance development when using more than one active (Leathwick et al, 2009, cited in Bartram et al, 2012). These are as follows:

  • Resistance to the different chemical classes must be under independent genetic control.
  • Resistance alleles are functionally recessive under treatment.
  • There must be a low frequency of resistant alleles.
  • The efficacy of each of the component anthelmintics against the susceptible genotypes should approach 100 per cent.
  • A proportion of the population is not exposed to treatment to ensure surviving resistant genotypes are diluted in a pool of susceptible genotypes (in refugia effect).
  • Anthelmintics in the product have similar duration of persistent action.

Following on from this, computer modelling of sheep nematode populations has been used to indicate the ability of multiple actives to slow the rate of anthelmintic resistance development, provided certain criteria are met. The most important criteria appear to be the opportunity for survival of susceptible nematodes in refugia and the pre-existing levels of resistance to each anthelmintic in the product (Bartram et al, 2012). Unfortunately, data to support these computer models have proven difficult to generate given the slow population dynamics and the lack of genetic markers for resistant traits (Gilleard and Beech, 2007, cited in Bartram et al, 2012).

Enable nematode control in the presence of drug resistance

Ideally, dual active products should only be used when resistant alleles are at a very low frequency and, therefore, all the anthelmintics in the product are still fully effective. If resistance is relatively common to each active then the use of both together may provide improved clinical response for a few years if used carefully, through the additive effect described in Panel 1 (SCOPS, 2012).

In the UK, the frequency of 3-ML-resistant alleles within the gastrointestinal (GI) nematodes may be quite low on some farms; however, resistance is certainly on the rise, particularly with the increasing use of 3-ML products in the control of sheep scab. This means it is particularly important to integrate the new dual active product into worm control plans now. It is also essential the Sustainable Control of Parasites in Sheep (SCOPS) principles are followed to maintain the efficacy of this product for as long as possible. These include using management practices, such as correct dose calculation and administration, which seek to maximise efficacies, as well as maximising the benefits from the in refugia dilution effect.

If it is possible to reduce the number of resistant worms that remain within a worm population after treatment (by using a more effective wormer), there will be maximum benefit achieved by the use of the in refugia dilution effect. The example in Panel 2 indicates this in more detail.

Panel 2 shows how for less effective wormers the impact of the in refugia worm population on diluting resistant worms will be much reduced. It is therefore extremely important to utilise the principle of the in refugia dilution effect even when the wormers used are still highly effective on a particular farm. This will help to reduce the rate of resistance development to those wormers, thus keeping those wormers useful on that farm for longer.

A number of studies have been carried out to confirm efficacy of the new dual active against anthelmintic-resistant GI nematodes in sheep. It is important to bear in mind these studies have been designed and funded, and the data was analysed by the animal health company that developed this product, although the company was not involved in actual data collection.

Concerns over the use of dual or multiple actives include:

  • the potential to select for multiple-resistant parasites if there is not a good in refugia population available
  • the potential for shared mechanisms for resistance between chemical classes
  • the fact pre-existing levels of anthelmintic resistance on some farms may be too high to introduce multiple actives

When to use a dual active

SCOPS is an industry-led body formed to develop sustainable strategies for parasite control in sheep, in response to the ever-increasing threat of anthelmintic resistance to the future heath and profitability of the UK sheep industry.

With the earlier reports of resistance to the new 4-AD group of anthelmintics in the Netherlands, SCOPS is urging vets, advisors and farmers to follow its advice regarding the integration of the newer classes of wormer (including the dual active containing derquantel) into their worm control programmes. SCOPS advice regarding the use of new wormers has been and remains as follows:

  • Any new products should be central to quarantine strategies, with the aim of preventing the introduction of resistant parasites on to a farm. The quarantine strategy recommended is to drench with a wormer from one of the two new groups – either 4-AD or 5-SI, plus oral moxidectin (or alternatively use one per cent injectable moxidectin if there is a risk of sheep scab). The sheep should then be held off any pasture for 24 to 48 hours until all the worm eggs in the gut have passed out in faeces. The sheep should then be turned out on to contaminated ground to minimise the impact of any worms that survive the treatments on the farm’s anthelmintic resistance status.
  • New compounds should be used strategically and only when necessary.
  • New compounds should not be left in reserve for when other groups have failed. It is important they are integrated into worm control plans alongside existing products to prolong the life of the existing products, with greater emphasis placed on management actions aimed at reducing overall dependence on anthelmintics.
  • To integrate new groups effectively the anthelmintic resistance status of the farm should be known.
  • Every effort should be made to maintain a high proportion of in refugia worms (worms that are not exposed to the anthelmintic – this includes worms in untreated sheep and free-living larval stages on the pasture) on the farm.

The situation on every farm in terms of management practices and anthelmintic resistance status varies enormously. As a result there can never be a blueprint formula for how and when to use a particular anthelmintic product. However, it is essential when formulating a worm control plan for a particular farm, the advisor has a good working knowledge of the management practices and resistance status specific to that farm, as well as a clear understanding of the products available.

One final word would be that to ensure safety, quality, efficacy and legal compliance, it is important only licenced products containing more than one active are used and that mixtures of more than one anthelmintic are never prepared on farm (Bartram et al, 2012).

References and further reading

  • Abbott K A, Taylor M A and Stubbings L A (2012). Sustainable Worm Control Strategies for Sheep (4th edn), Technical Manual for Veterinary Surgeons and Advisers, Sustainable Control of Parasites in Sheep (SCOPS), available online at www.scops.org.uk
  • Bartram D J, Leathwick D M, Taylor M A, Guerden T and Maeder S J (2012). The role of combination anthelmintic formulations in the sustainable control of sheep nematodes, Vet Parasitol 186(3-4): 151-158.
  • Entrocasso C, Alvarez L, Manazza J, Lifschitz A, Borda B, Virkel G, Mottier L and Lanusse C (2008). Clinical efficacy assessment of the albendazole–ivermectin combination in lambs parasitized with resistant nematodes, Vet Parasitol 155(3-4): 249-256.
  • Geurden T, Slootmans N, Glover M and Bartram D J (2014). Production benefit of treatment with a dual active oral formulation of derquantel-abamectin in slaughter lambs, Vet Parasitol 205(1): 405-407.
  • Gilleard J S and Beech R N (2007). Population genetics of anthelmintic resistance in parasitic nematodes, Parasitology 134(pt 8): 1,133-1,147.
  • Leathwick D M, Hosking B C, Bisset S A and McKay C H (2009). Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class? NZ Vet J 57(4): 181-192.
  • Webb J L (1963). Effect of more than one inhibitor. In Enzyme and Metabolic Inhibitors, Academic Press, New York 1: 66-79, 487-512.

With the rise in anthelmintic resistance, the author says it is important to integrate dual active products into worm control plans and follow the Sustainable Control of Parasites in Sheep principles.

IMAGE: The Kennel Club.